- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 311/45 - Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
Patent holdings for IPC class C07C 311/45
Total number of patents in this class: 14
10-year publication summary
|
0
|
0
|
1
|
2
|
4
|
2
|
0
|
0
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Galapagos NV | 273 |
3 |
| AbbVie Global Enterprises Ltd. | 13 |
3 |
| TopoTarget UK Limited | 14 |
2 |
| AbbVie S.á.r.l. | 27 |
1 |
| AMOREPACIFIC Corporation | 2850 |
1 |
| Georgetown University | 620 |
1 |
| Icahn School of Medicine at Mount Sinai | 973 |
1 |
| Numed International, Inc. | 1 |
1 |
| MSN Research & Development Center | 1 |
1 |
| Other owners | 0 |